Mironid Limited
Research and experimental development on biotechnology · Glasgow
ActiveUnited KingdomIncorporated 2014Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
SC476430- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2014-04-29
- Jurisdiction
- —
- Registered office
- ARBUTHNOTT BUILDING (HAMNETT WING), 161 CATHEDRAL STREET, GLASGOW, G4 0RE, SCOTLAND
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
3 SH01-derived rounds2026-05-19
£11,499,993 raised
£65,948,568 estimated post-money
2026-03-31
£19,938,664 raised
£39,356,185 estimated post-money
2023-03-31
£8,178,349 raised
£21,103,926 estimated post-money
Research and innovation
4 matched grantsExtending Mironid's PDE4 activator programme: Hyperparathyroidism as a second clinical indicationLead
Innovate UK · Collaborative R&D · 2023-03-01 – 2024-02-29
£501,892
awarded
Small molecule activators of cAMP PDE4 long isoforms for immuno-oncologyLead
Innovate UK · Feasibility Studies · 2018-04-01 – 2019-06-30
£135,066
awarded
Investigating the renal microvasculature in polycystic kidney diseaseMRC · Research Grant · 2017-09-20 – 2020-09-29 · with 7 other participants£404,871whole project
Investigating the renal microvasculature in polycystic kidney disease
MRC · Research Grant · 2017-09-20 – 2020-09-29 · with 7 other participants
£404,871
whole project
University College LondonleadMayo ClinicMironid LtdUniversity College LondonUniversity of HelsinkiUniversity of TorontoVector BioLabsWashington University in St Louis
Small molecule activators of cAMP PDE4 long isoforms for the treatment of ADPKDLead
Innovate UK · Collaborative R&D · 2017-01-01 – 2017-09-30
£424,678
awarded